Rhythm Pharmaceuticals Shares Rise Following Reports of Potential Second Bidder
Rhythm Pharmaceuticals (RYTM) saw its stock price increase by 4.2% following reports that a second bidder may be interested in acquiring the biotechnology company. Market speculation suggests that one of the world's largest pharmaceutical firms has potentially issued a counteroffer. The news stems from an unconfirmed alert circulated by Betaville. While the report remains speculative, the possibility of increased competition for the biotech firm has driven positive momentum in its share price.
Tickers: $RYTM
Topics: biotechnology mergers and acquisitions stock price movement
Read the full article at Seeking Alpha
Part of the story Rhythm Pharmaceuticals gains on report of additional bidder (2 articles)